4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-030986
Options or other derivatives
- Director acquired 23,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schor Chen · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | D |
Loading xslF345X03/doc4.xml…